Nicholas J Parziale, MD
Neurology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Parziale’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A114345 · Current
Licensed to practise in California · since 2010 · expires 2028-03-31 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$737,289
Pharmacies billed $737,289 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (16 of 833) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%. Long-acting opioids: 75% of their opioid prescriptions.
735 generic and fewer than 11 brand-name prescriptions · $737,289 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Radicava Ors | None | 35 | $483,535 | $13,815 |
| Neupro | None | 12 | $13,067 | $1,089 |
| Carbidopa-Levodopa | None | 165 | $10,698 | $65 |
| Glatopa | None | 12 | $8,556 | $713 |
| Emgality | Migraine | 11 | $8,303 | $755 |
See all 22 drugs
| Radicava Ors | None | 35 | $483,535 | $13,815 |
| Neupro | None | 12 | $13,067 | $1,089 |
| Carbidopa-Levodopa | None | 165 | $10,698 | $65 |
| Glatopa | None | 12 | $8,556 | $713 |
| Emgality | Migraine | 11 | $8,303 | $755 |
| Mycophenolate Mofetil | None | 36 | $4,920 | $137 |
| Pyridostigmine | None | 44 | $2,874 | $65 |
| Riluzole | None | 55 | $2,068 | $38 |
| Propranolol | None | 24 | $1,884 | $79 |
| Levetiracetam | None | 38 | $1,737 | $46 |
| Primidone | None | 16 | $936 | $58 |
| Divalproex Sodium Er | None | 12 | $780 | $65 |
| Divalproex | None | 14 | $667 | $48 |
| Gabapentin | None | 33 | $659 | $20 |
| Phenytoin Sodium Extended | None | 12 | $557 | $46 |
| Carbidopa-Levodopa Er | None | 22 | $424 | $19 |
| Lamotrigine | None | 13 | $325 | $25 |
| Ropinirole | None | 17 | $299 | $18 |
| Atorvastatin | None | 21 | $293 | $14 |
| Baclofen | None | 12 | $225 | $19 |
| Prednisone | None | 13 | $186 | $14 |
| Methadone | None | 12 | $163 | $14 |
Year by year
| 2024 | 833 | 193 | 2% (16) | None | $737,289 |
| 2023 | 826 | 187 | 3% (23) | 20% | $1,126,615 |
| 2022 | 721 | 170 | 2% (15) | 16% | $370,805 |
| 2021 | 612 | 162 | None | 15% | $115,591 |
| 2020 | 469 | 143 | None | 13% | $166,034 |
| 2019 | 480 | 157 | None | None | $96,051 |
| 2018 | 329 | 114 | None | 13% | $65,841 |
| 2017 | 256 | 87 | 0% (0) | 13% | $53,564 |
| 2016 | 343 | 58 | None | 26% | $423,988 |
| 2015 | 348 | 81 | None | 18% | $221,824 |
| 2014 | 182 | 44 | None | None | $136,871 |
| 2013 | 51 | 14 | None | None | $5,581 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Relyvrio | 42 | $553,860 | $13,187 |
| Radicava Ors | 35 | $458,678 | $13,105 |
| Neupro | 16 | $17,659 | $1,104 |
| Carbidopa-Levodopa | 144 | $10,840 | $75 |
| Ubrelvy | 11 | $9,136 | $831 |
| Glatopa | 12 | $8,556 | $713 |
| Pyridostigmine | 26 | $3,057 | $118 |
| Mycophenolate Mofetil | 14 | $2,056 | $147 |
| Propranolol | 28 | $1,975 | $71 |
| Levetiracetam | 45 | $1,813 | $40 |
| Riluzole | 19 | $1,505 | $79 |
| Primidone | 19 | $1,130 | $59 |
| Memantine | 17 | $1,012 | $60 |
| Gabapentin | 37 | $757 | $20 |
| Divalproex | 11 | $502 | $46 |
| Carbidopa-Levodopa Er | 14 | $470 | $34 |
| Atorvastatin | 21 | $461 | $22 |
| Lamotrigine | 13 | $365 | $28 |
| Ropinirole | 13 | $263 | $20 |
| Prednisone | 18 | $229 | $13 |
| Baclofen | 16 | $140 | $9 |
| Methadone | 13 | $139 | $11 |
2022: 19 drugs
| Radicava Ors | 11 | $154,435 | $14,040 |
| Sodium Phenylbutyrate | 11 | $55,786 | $5,071 |
| Ubrelvy | 28 | $22,345 | $798 |
| Neupro | 15 | $19,296 | $1,286 |
| Carbidopa-Levodopa | 156 | $12,666 | $81 |
| Pyridostigmine | 21 | $4,245 | $202 |
| Mycophenolate Mofetil | 21 | $3,112 | $148 |
| Riluzole | 12 | $2,361 | $197 |
| Levetiracetam | 32 | $1,878 | $59 |
| Propranolol | 20 | $1,692 | $85 |
| Sumatriptan | 14 | $1,631 | $116 |
| Primidone | 17 | $1,206 | $71 |
| Gabapentin | 27 | $916 | $34 |
| Divalproex | 18 | $789 | $44 |
| Prednisone | 29 | $512 | $18 |
| Atorvastatin | 25 | $455 | $18 |
| Lamotrigine | 17 | $438 | $26 |
| Memantine | 11 | $271 | $25 |
| Methadone | 14 | $151 | $11 |
2021: 18 drugs
| Neupro | 17 | $21,257 | $1,250 |
| Ubrelvy | 20 | $16,792 | $840 |
| Carbidopa-Levodopa | 124 | $9,598 | $77 |
| Pyridostigmine | 19 | $3,849 | $203 |
| Riluzole | 19 | $3,674 | $193 |
| Mycophenolate Mofetil | 21 | $3,112 | $148 |
| Levetiracetam | 20 | $2,509 | $125 |
| Gabapentin | 35 | $1,359 | $39 |
| Propranolol | 16 | $1,331 | $83 |
| Tetrabenazine | 12 | $1,265 | $105 |
| Glycopyrrolate | 13 | $1,161 | $89 |
| Carbidopa-Levodopa Er | 16 | $1,074 | $67 |
| Primidone | 13 | $961 | $74 |
| Divalproex | 15 | $867 | $58 |
| Memantine | 15 | $609 | $41 |
| Prednisone | 26 | $546 | $21 |
| Atorvastatin | 26 | $419 | $16 |
| Pramipexole Dihydrochloride | 11 | $234 | $21 |
2020: 12 drugs
| Northera | 17 | $103,581 | $6,093 |
| Neupro | 15 | $14,864 | $991 |
| Carbidopa-Levodopa | 95 | $8,250 | $87 |
| Mycophenolate Mofetil | 21 | $3,243 | $154 |
| Riluzole | 23 | $3,063 | $133 |
| Levetiracetam | 21 | $1,963 | $93 |
| Tetrabenazine | 11 | $1,952 | $177 |
| Propranolol | 15 | $1,424 | $95 |
| Gabapentin | 21 | $936 | $45 |
| Divalproex | 13 | $926 | $71 |
| Prednisone | 15 | $351 | $23 |
| Lamotrigine | 13 | $273 | $21 |
2019: 11 drugs
| Carbidopa-Levodopa | 105 | $7,952 | $76 |
| Riluzole | 29 | $5,662 | $195 |
| Mycophenolate Mofetil | 21 | $3,888 | $185 |
| Carbamazepine Er | 12 | $3,018 | $252 |
| Pyridostigmine | 11 | $2,400 | $218 |
| Tetrabenazine | 12 | $2,242 | $187 |
| Levetiracetam | 30 | $1,941 | $65 |
| Gabapentin | 24 | $1,273 | $53 |
| Divalproex | 21 | $1,057 | $50 |
| Prednisone | 19 | $353 | $19 |
| Lorazepam | 14 | $74 | $5 |
2018: 8 drugs
| Glatopa | 13 | $27,573 | $2,121 |
| Tetrabenazine | 12 | $4,600 | $383 |
| Carbidopa-Levodopa | 57 | $3,837 | $67 |
| Mycophenolate Mofetil | 12 | $3,193 | $266 |
| Levetiracetam | 15 | $630 | $42 |
| Gabapentin | 16 | $542 | $34 |
| Clopidogrel | 12 | $355 | $30 |
| Prednisone | 13 | $216 | $17 |
2017: 6 drugs
| Carbidopa-Levodopa | 18 | $1,267 | $70 |
| Carbidopa-Levodopa Er | 30 | $908 | $30 |
| Primidone | 12 | $708 | $59 |
| Atorvastatin | 14 | $702 | $50 |
| Levetiracetam | 19 | $570 | $30 |
| Gabapentin | 11 | $287 | $26 |
2016: 12 drugs
| Privigen | Immune globulin | 12 | $142,550 | $11,879 |
| Riluzole | None | 32 | $12,451 | $389 |
| Lyrica | None | 13 | $10,435 | $803 |
| Mycophenolate Mofetil | None | 17 | $2,375 | $140 |
| Gabapentin | None | 30 | $971 | $32 |
| Baclofen | None | 18 | $737 | $41 |
| Levetiracetam | None | 19 | $572 | $30 |
| Dantrolene | None | 11 | $504 | $46 |
| Amitriptyline | None | 11 | $485 | $44 |
| Glycopyrrolate | None | 14 | $379 | $27 |
| Prednisone | None | 12 | $127 | $11 |
| Sertraline | None | 13 | $109 | $8 |
2015: 9 drugs
| Octagam | Immune globulin | 12 | $95,385 | $7,949 |
| Duloxetine | None | 24 | $5,041 | $210 |
| Lyrica | None | 13 | $3,974 | $306 |
| Mycophenolate Mofetil | None | 45 | $3,897 | $87 |
| Riluzole | None | 12 | $3,435 | $286 |
| Gabapentin | None | 45 | $1,326 | $29 |
| Azathioprine | None | 14 | $1,211 | $87 |
| Baclofen | None | 16 | $314 | $20 |
| Prednisone | None | 22 | $164 | $7 |
2014: 3 drugs
| Gabapentin | 40 | $1,465 | $37 |
| Baclofen | 12 | $302 | $25 |
| Carbamazepine | 12 | $243 | $20 |
2013: 1 drug
| Gabapentin | 20 | $545 | $27 |
Money from drug and device companies
$125 in 2024
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Ultomiris | $125 | 1 payment
|
See the published payment
| Alexion Pharmaceuticals | Meals · 2024-05-02 | Ultomiris | $125 |
Professional record
- NPI
- 1144484999
- Licence
- CA A114345California A114345: Current · expires 2028-03-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 300 Medical Plz, Suite B-200, Los Angeles, CA, 90095
- NPI first listed
- 2008-07-10
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.